Survivor Patients

2

Review clinical trials related to Survivor Patients. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Helping Young People With Testicular Cancer Using Virtual and Extended Reality

TRANSCEND-XR is a European research project designed to better support adolescents and young adults who have been cured of testicular cancer. Even after treatment has ended, many young people continue to face physical, psychological, or social difficulties that are often poorly understood and insufficiently addressed. The project aims to develop an innovative digital tool using extended reality (XR) to help these young people better understand the potential long-term effects of the disease and its treatments, recognize signs that require medical attention, and become more active participants in their own health follow-up. TRANSCEND-XR first includes a pilot phase to test feasibility and improve the tool, followed by a larger clinical study comparing its use with usual medical follow-up. Researchers will assess, in particular, its impact on patients' knowledge, quality of life, and ability to seek help. The ultimate goal is to sustainably improve information, autonomy, and well-being among young survivors of testicular cancer through a digital approach tailored to their needs and daily practices.

Participants needed: 245
Trial details
Age: 15-39Biological sex: MaleType: InterventionalSponsor: Gustave Roussy, Cancer Campus, Grand ParisUpdated: May 6, 2026
Eligibility criteria

Any person assigned male at birth who is diagnosed with stage I-III TC (germ cel... [+8]

Non-testicular germ cell tumours (e.g., mediastinal primary or retroperitoneal p... [+8]

Status: Recruiting

A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain

The are doing this study to find out whether using topical (on the skin) herbal plasters, Tibetree pain- relieving plasters (PRPs), can be an effective addition to standard opioid therapy for pain management. The researchers will look at whether the Tibetree PRPs are a practical (feasible) and effective way of managing localized pain (pain that is limited to a certain area) in people who are currently taking opioids. Participants in this study will have cancer or have had it in the past.

Participants needed: 150
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Mar 4, 2026Locations: 7
Eligibility criteria

English speaking with age ≥ 18 years or older [+7]

Patients are unwilling to reduce opioid use if their pain reduces [+10]